BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35000202)

  • 1. Diverse facets of MDSC in different phases of chronic HBV infection: Impact on HBV-specific T-cell response and homing.
    Pal S; Dey D; Chakraborty BC; Nandi M; Khatun M; Banerjee S; Santra A; Ghosh R; Ahammed SM; Chowdhury A; Datta S
    Hepatology; 2022 Sep; 76(3):759-774. PubMed ID: 35000202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
    Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
    Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaceted Defects in Monocytes in Different Phases of Chronic Hepatitis B Virus Infection: Lack of Restoration after Antiviral Therapy.
    Dey D; Pal S; Chakraborty BC; Baidya A; Bhadra S; Ghosh R; Banerjee S; Ahammed SKM; Chowdhury A; Datta S
    Microbiol Spectr; 2022 Dec; 10(6):e0193922. PubMed ID: 36445121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8
    Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
    Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection.
    Yang F; Yu X; Zhou C; Mao R; Zhu M; Zhu H; Ma Z; Mitra B; Zhao G; Huang Y; Guo H; Wang B; Zhang J
    PLoS Pathog; 2019 Apr; 15(4):e1007690. PubMed ID: 30998767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B.
    Chua C; Salimzadeh L; Ma AT; Adeyi OA; Seo H; Boukhaled GM; Mehrotra A; Patel A; Ferrando-Martinez S; Robbins SH; La D; Wong D; Janssen HLA; Brooks DG; Feld JJ; Gehring AJ
    Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis B e antigen from chronic hepatitis B patients induces Th1/Th2 cytokine imbalance in vitro].
    Han YP; Li J; Jiang LF; Xu QQ; Liu B; Dong L; Chen N; Kong LH; Xie FR; Huang ZH
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):584-9. PubMed ID: 24119737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.
    Park JJ; Wong DK; Wahed AS; Lee WM; Feld JJ; Terrault N; Khalili M; Sterling RK; Kowdley KV; Bzowej N; Lau DT; Kim WR; Smith C; Carithers RL; Torrey KW; Keith JW; Levine DL; Traum D; Ho S; Valiga ME; Johnson GS; Doo E; Lok AS; Chang KM;
    Gastroenterology; 2016 Mar; 150(3):684-695.e5. PubMed ID: 26684441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection.
    Jacobi FJ; Wild K; Smits M; Zoldan K; Csernalabics B; Flecken T; Lang J; Ehrenmann P; Emmerich F; Hofmann M; Thimme R; Neumann-Haefelin C; Boettler T
    J Hepatol; 2019 Jun; 70(6):1103-1113. PubMed ID: 30826436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed death 1 expressing CD8
    Khanam A; Tang LSY; Kottilil S
    Hepatology; 2022 Mar; 75(3):690-708. PubMed ID: 34689344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of tenofovir disoproxil fumarate antiviral therapy on virus-specific CD8+T Cells function in patients with chronic hepatitis B].
    Duan SP; Zhu LH; Hou LJ; Wang HW; Zhu XW; Hao J
    Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):421-426. PubMed ID: 34107578
    [No Abstract]   [Full Text] [Related]  

  • 12. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
    Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B.
    Li MH; Lu Y; Zhang L; Wang XY; Ran CP; Hao HX; Zhang D; Qu XJ; Shen G; Wu SL; Cao WH; Qi TL; Liu RY; Hu LP; Chang M; Hua WH; Liu SA; Wan G; Xie Y
    Chin Med J (Engl); 2018 Aug; 131(15):1813-1818. PubMed ID: 30058578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polarization of Monocytic Myeloid-Derived Suppressor Cells by Hepatitis B Surface Antigen Is Mediated via ERK/IL-6/STAT3 Signaling Feedback and Restrains the Activation of T Cells in Chronic Hepatitis B Virus Infection.
    Fang Z; Li J; Yu X; Zhang D; Ren G; Shi B; Wang C; Kosinska AD; Wang S; Zhou X; Kozlowski M; Hu Y; Yuan Z
    J Immunol; 2015 Nov; 195(10):4873-83. PubMed ID: 26416274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B].
    Xie DY; Lin BL; Chen FJ; Deng H; Chong YT; Zhang XH; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):646-50. PubMed ID: 20943073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B.
    Xie S; Yang L; Bi X; Deng W; Jiang T; Lin Y; Wang S; Zhang L; Liu R; Chang M; Wu S; Gao Y; Hao H; Shen G; Xu M; Chen X; Hu L; Lu Y; Song R; Xie Y; Li M
    Front Immunol; 2022; 13():1036612. PubMed ID: 36353632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-induced IL-10.
    Huang A; Zhang B; Yan W; Wang B; Wei H; Zhang F; Wu L; Fan K; Guo Y
    J Immunol; 2014 Dec; 193(11):5461-9. PubMed ID: 25344470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.
    Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ
    Front Immunol; 2020; 11():1299. PubMed ID: 32719675
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
    Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
    Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.